ストックスクリーナーアプリを入手
416.31
0.40%
-1.68
アフターアワーズ：
415.75
-0.56
-0.13%
前日終値:
$417.99
開ける：
$418.31
24時間の取引高:
2.76M
Relative Volume:
1.01
時価総額：
$157.15B
収益：
$42.90B
当期純損益:
$6.52B
株価収益率:
24.42
EPS:
17.05
ネットキャッシュフロー:
$6.72B
1週間 パフォーマンス:
-0.85%
1か月 パフォーマンス:
+2.77%
6か月 パフォーマンス:
-25.89%
1年 パフォーマンス:
-25.05%
1日の値動き範囲:
$413.78
$420.55
1週間の範囲:
$413.78
$438.49
52週間の値動き範囲:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
416.31 | 158.50B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
193.30 | 143.82B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.57 | 43.48B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.43 | 34.46B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.64 | 28.03B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Thermo Fisher Scientific Inc. Ranks 83rd in Trading Volume with 11.51 Billion Shares Exchanged Amid Acquisition News and Strong Financial Results - AInvest
Thermo Fisher acquires Sanofi's New Jersey manufacturing site - Reuters
Thermo Fisher and Sanofi Expand Partnership to Enable Manufacturing - New Jersey Business Magazine
Thermo Fisher Scientific price target lowered to $550 by TD Cowen - Investing.com
Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase - Fierce Pharma
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Preclinical CRO Market Size at USD 6.8 Billion in 2025, Forecasted to Grow at 8.73% CAGR Through 2034 - GlobeNewswire Inc.
Thermo Fisher acquires Sanofi’s New Jersey manufacturing site By Reuters - Investing.com
Thermo Fisher Acquires Sanofi's New Jersey Manufacturing Site - US News Money
Thermo Fisher Scientific, Sanofi Expand Strategic Partnership - Contract Pharma
Thermo Fisher Scientific Signs Deal To Buy Sanofi's Steriles Manufacturing Site In Ridgefield - Nasdaq
Thermo Fisher to buy Sanofi's U.S. production site (TMO:NYSE) - Seeking Alpha
Thermo Fisher to acquire Sanofi’s sterile manufacturing site in New Jersey - Investing.com India
Thermo Fisher Expands US Pharma Manufacturing With Key Sanofi Facility Acquisition - Stock Titan
Thermo Fisher Scientific introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System - SelectScience
Thermo Fisher Scientific (TMO) Unveils Next-Day Genomic Profiling With Oncomine Assay Plus - Yahoo Finance
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Peering Into Thermo Fisher Scientific's Recent Short Interest - 富途牛牛
Is Thermo Fisher Scientific Inc.'s (NYSE:TMO) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo Finance
Grain Analysis Market: Emerging Technologies and Global - openPR.com
Protein Purification & Isolation Market Gains Momentum, 10.5% - openPR.com
Thermo Fisher introduces new assay to help advance future of precision medicine - BioSpectrum Asia
Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine - BioSpace
Are Options Traders Betting on a Big Move in Thermo Fisher Stock? - The Globe and Mail
Scotiabank Upgrades Thermo Fisher (TMO) to Outperform, Lowers PT - MSN
Thermo Fisher's $4.1B Bid for Solventum: A Play for Biologics Dominance and AI-Driven Growth - AInvest
Wolfe Research Adjusts PT on Thermo Fisher Scientific to $485 From $500, Maintains Outperform Rating - MarketScreener
HSBC Adjusts Price Target on Thermo Fisher Scientific to $540 From $560, Maintains Buy Rating - MarketScreener
European Commission OKs Thermo Fisher's Purchase of Solventum's Purification, Filtration Arm - MarketScreener
13 Best Large Cap Stocks to Buy Right Now - Insider Monkey
Thermo Fisher Receives Buy Rating from Wells Fargo Analyst Brandon Couillard. - AInvest
Thermo Fisher Scientific (TMO): Riding Out Policy Storms to Capture Life Sciences Dominance - AInvest
Thermo Fisher Scientific Ranks 63rd in Trading Volume with 10.88 Billion as it Expands US Manufacturing - AInvest
This Thermo Fisher Scientific Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga
Thermo Fisher Scientific stock rating upgraded by Scotiabank to Sector Outperform - Investing.com
13 Analysts Assess Thermo Fisher Scientific: What You Need To Know - Nasdaq
Scotiabank Upgrades Thermo Fisher Scientific to Sector Outperform From Sector Perform, Adjusts PT to $590 From $605 - MarketScreener
Thermo Fisher Scientific Declares Quarterly DividendJuly 10, 2025 - BioSpace
Thermo Fisher Scientific declares $0.43 quarterly dividend By Investing.com - Investing.com Australia
Thermo Fisher Scientific declares $0.43 quarterly dividend - Investing.com
The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo Fisher Scientific and FONAR - Yahoo Finance
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? - MSN
Top Research Reports for SAP, Novo Nordisk & Thermo Fisher - Yahoo Finance
Thermo Fisher Scientific downgraded at UBS on life sciences R&D headwinds - Seeking Alpha
Behind the Scenes of Thermo Fisher Scientific's Latest Options Trends - Nasdaq
This Thermo Fisher Scientific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Thermo Fisher’s Oncomine Dx Express Test Receives FDA Approval - Insider Monkey
Thermo Fisher Scientific (TMO) Traded Down due to Concerns Over Spending Cuts - Insider Monkey
Thermo Fisher Scientific: Recovery In Sight, Attractively Valued (NYSE:TMO) - Seeking Alpha
Wells Fargo maintained a Buy rating on Thermo Fisher Scientific (TMO) - MSN
FDA Approved Thermo Fisher Scientific’s (TMO) Oncomine Dx Express Test - Insider Monkey
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
1.16%
大文字化:
|
ボリューム (24 時間):